2001
DOI: 10.1002/humu.10011
|View full text |Cite
|
Sign up to set email alerts
|

Two novel types of contiguous gene deletion of the AVPR2 and ARHGAP4 genes in unrelated Japanese kindreds with nephrogenic diabetes insipidus

Abstract: Study of two families containing individuals with nephrogenic diabetes insipidus (NDI) indicated different types of 21.3 kb and 26.3 kb deletions involving the AVPR2 and ARHGAP4 (RhoGAP C1) genes. In the case of the 21.3 kb deletion, the deletion consensus motif (5'-TGAAGG-3') and polypurine runs, known as the arrest site of polymerase alpha, were detected in the vicinity of the deletion junction. Inverted repeats (7/8 matches), believed to potentiate DNA loop formation, flank the deletion breakpoint. We propo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
32
1

Year Published

2003
2003
2012
2012

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 39 publications
(36 citation statements)
references
References 7 publications
3
32
1
Order By: Relevance
“…similar mutation process involving the ICS motif was proposed for a previously reported contiguous gene deletion involving AVPR2 and ARHGAP4. 25 In addition an extrachromosomal substrate assay for ICS recombination also highlights the central role of the ICS motif in recombination that involves excision of an intervening sequence. 26 Interestingly, no symptoms specific to the ARHGAP4 gene were identified in our patients.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…similar mutation process involving the ICS motif was proposed for a previously reported contiguous gene deletion involving AVPR2 and ARHGAP4. 25 In addition an extrachromosomal substrate assay for ICS recombination also highlights the central role of the ICS motif in recombination that involves excision of an intervening sequence. 26 Interestingly, no symptoms specific to the ARHGAP4 gene were identified in our patients.…”
Section: Discussionmentioning
confidence: 99%
“…Contiguous deletions involving AVPR2 and ARH-GAP4 have been reported on two previous occasions, with the NDI phenotype not being compounded in either instance. 25,27 ARHGAP4 encodes a cytoplasmic protein of 115 kD that is preferentially expressed in hematopoietic cells. One patient with a contiguous deletion of ARHGAP4 and AVPR2 was followed over a 16-year period and included extensive analysis of blood chemical, enzyme and hormone values and showed no deviations from normal ranges other than those related to the CNDI phenotype.…”
Section: Discussionmentioning
confidence: 99%
“…Molecular analysis for each individual case is indispensable for contemporary medicine [15]. Our case was revealed to have a contiguous deletion of AVPR2 and ARHGAP4 (RhoGAP C1) genes [14]. As, except for a possibly milder phenotype in patients with a G185C mutation, no clear relationship between clinical and genetic data could be found [15], our patient is not thought to be a special case for evaluation of treatment.…”
Section: Discussionmentioning
confidence: 99%
“…The diagnosis of NDI was confirmed by a lack of response of the urinary osmolality to fluid restriction and 1-deamino-8- D -AVP administration. Later, molecular examination revealed a contiguous deletion of AVPR2 and ARHGAP4 (RhoGAP C1) genes [14](patient No. 1 in this report).…”
Section: Case Reportmentioning
confidence: 99%
“…Prehybridization, hybridization and probe labeling were performed using alkPhos Direct (ge healthcare uk Ltd., Buckinghamshire, england), as reported previously [8]. The probes comprised the PCr products, using the following forward and reverse primers for the PTh promoter region (2986 bp): 5'-aag Cag TTC aCa CTC aaa Tga CCa aCa-3' and 5'-TCC aaa agC TTC TCa Tga aaa CCa aCC-3'.…”
Section: Southern Blot Analysis For the Pth Promotermentioning
confidence: 99%